Prostatis Group’s Qorvo QRVO Stock Holding History

Prostatis Group’s Portfolio QRVO Stock Details QRVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-12,754	Closed	-$12.8K	–	194
2023 Q2	$12.8K	Buy	+12,754	New	+$1.22M	0.01%	242

Other funds holding QRVO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

VVP

Vulcan Value Partners Birmingham, Alabama $3.29B AUM 6.08% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Prostatis Group's QRVO Position: Q3 2023 in Review

Prostatis Group sold out of Qorvo (QRVO) in Q3 2023, closing a stake of 12,754 shares — an estimated $12.8K sold.

Prostatis Group first reported a position in QRVO in Q2 2023 and held it in 1 quarter. The position peaked at $12.8K in Q2 2023. 542 funds tracked by Wall St. Rank hold QRVO as of Q3 2023.

Prostatis Group reported no remaining Qorvo position as of Q3 2023 after selling out during the quarter.
Prostatis Group sold 12,754 Qorvo shares in Q3 2023, an estimated $12.8K.
Prostatis Group first reported a position in Qorvo in Q2 2023 and held it in 1 quarter.
Prostatis Group's Qorvo position peaked at $12.8K in Q2 2023.
542 funds tracked by Wall St. Rank held Qorvo as of Q3 2023.

Based on Prostatis Group's 13F filing for Q3 2023, filed 21 Mar 2025.